Study summary · research use only
[The effect of thymogen on the heart in ischemia and reperfusion]
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
In this study using an isolated heart model, with the species not specified, the anti-ischemic properties of thymogen were examined. The abstract reports that its cardioprotective effect was described as higher than that of dalargin and verapamil, and that the anti-ischemic action of thymogen was realized without participation of opiate receptors and without blockade of calcium entry into cardiomyocytes.
Abstract
The anti-ischemic properties of thymogen were studied on an isolated heart model. Its cardioprotective effect was higher than that of dalargin and verapamil. The mechanism of the thymogen anti-ischemic action is realized without the participation of the opiate receptors and blockade of calcium entrance into the cardiomyocytes.
pepmg summarizes the peer-reviewed literature and links to every source. It sells nothing and ships nothing. Where an FDA label, a peer-reviewed study or a clinical-trial registry entry (labeled trial registry, not peer-reviewed) has published a dose, pepmg reports it with the source named; it gives no personalized recommendations and no administration technique. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.